The influence of angiotensin II and aldosterone on the diuretic effects of atrial natriuretic peptide in isolated perfused rat kidneys;Der einfluss von aldosteron und angiotensin II auf die diuretische wirkung atrialen natriuretischen peptids (ANP)

Nieren- und Hochdruckkrankheiten

Volumn 27, Issue 12, 1998, Pages 533-538

  Heringlake, M ^a   Wagner, K ^a   Schumacher, J ^a   Schmucker, P ^a   Pagel, H ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Aldosterone; Angiotensin II; Atrial natriuretic peptide; Isolated perfused kidney

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; DIURESIS; HORMONE ACTION; NONHUMAN; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASODILATATION;

EID: 0032413968     PISSN: 03005224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Camargo M.J., H.D. Kleinert, S.A. Atlas, J.E. Sealey, J.H. Laragh, T. Maack: Ca-dependent hemodynamic and atriuretic effects of atrial extract in isolated rat kidney. Am. J. Physiol. 246, F447-F456 (1984).
2. Drummer C., M. Kentsch, W. Otter, M. Heer, M. Herten, R. Gerzer: Increased renal natriuretic peptide (urodilatin) excretion in heart failure patients. Eur. J. Med. Res. 2, 347-354 (1997).
3. Firth J.D., A.E.G.Raine, J.G.G.Ledingham: Low concentrations of ANP cause pressure dependent natriuresis in an isolated kidney. Am. J. Physiol. 255, F391-F396 (1988).
4. Gadano A., R. Moreau, F. Vachiery, T. Soupison, S. Yang, S. Cailmail, P. Sogni, A. Hadenque, F. Durand, D. Valla, D. Lebrec: Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites. J. Hepatol. 26, 1229-1234 (1997).
5. Harris P.J., D. Thomas, T.O. Morgan: Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption. Nature 526, 697-698 (1987).
6. Jespersen B., H. Eiskjaer, J.D. Jensen, C.E. Mogensen, S.S. Sorensen, E.B. Pedersen: Effects of high-dose atrial natriuretic peptide on renal hemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites. Scand. J. Clin. Lab. Invest. 55, 273-287 (1995).
7. Laragh J.H., J.E. Sealey: Renin-angiotensin-aldosterone system and the renal regulation of sodium, potassium and blood pressure homeostasis. In: Windhager E.E.: Handbook of Physiology, Section 8: Renal Physiology. Oxford University Press, New York 1992, 1464-1470.
8. Levy M.: Atrial natriuretic peptide: Renal effects in cirrhosis of the liver. Semin. Nephrol. 17, 520-529 (1997).
9. Levin E.R., D.G. Gardner, W.K. Samson: Natriuretic peptides. New Engl. J. Med. 339, 321-328 (1998).
10. Miller, A.W., D.F. Bohr, M.A. Schork, J.M. Terris: Hemodynamic responses to DOCA in young pigs. Hypertension 1, 591-597 (1979).
11. Pagel H., W. Jelkmann, C. Weiss: Isolated serum-free perfused rat kidneys release immunoreactive erythropoietin in response to hypoxia. Endocrinology 128, 2633-2638 (1991).
12. Perez-Ayuso R.M., V. Arroyo, R. Planas: Randomized, comparative study of efficiacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Gastroenterology 84, 961-968 (1983).
13. Rabelink T.J., H.A. Koomans, A. van de Stolpe, E.J.D. Mees: Effects of atrial natriuretic peptide on distal tubule function in humans. Kidney International 37, 996-1001 (1990).
14. Wehling M.: Novel aldosterone receptors: Specifity-conferring mechanism at the level of the cell membrane. Steroids 59, 160-163 (1994).
15. Yates N.E., J.P. Coghlan, J.M. Gregory, B.A. Scoggins, J.G. McDougall: Renal actions of atrial natriuretic factor: modulation of effect by changes in sodium status and aldosterone. Am. J. Physiol. 258, F684-F689 (1990).